Omnicell OMCL Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | $19.92M-13.7% | $23.09M+9.0% | $21.18M+69.1% | ||
| $77.38M-1.8% | $78.81M-0.2% | $78.96M-1.0% | $79.76M-1.5% | $80.96M-1.5% | ||
| $43.21M-2.9% | $44.5M+7.1% | $41.57M-0.9% | $41.96M+1.2% | $41.46M+5.5% | ||
| —— | —— | —— | —— | -$14.08M+5.2% | ||
| $2.41M-9.0% | $2.65M-12.4% | $3.03M-8.5% | $3.31M-6.9% | $3.55M-6.2% | ||
| —— | $0— | $0— | $0— | $0— | ||
| -$499K-2.3% | -$488K+49.9% | -$974K+7.1% | -$1.05M+0.1% | -$1.05M-7.4% | ||
| —— | —— | $12.14M+17.4% | $10.34M+230% | -$7.97M+52.4% | ||
| $5.96M+164% | -$9.28M-162% | $14.96M— | —— | —— | ||
| -$22.45M-8.0% | -$20.78M-163% | -$7.9M— | —— | —— | ||
| —— | —— | -$7.03M-21.3% | -$5.8M-84.3% | -$3.15M-34.9% | ||
| $1.7M-9.0% | $1.87M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $6.9M-11.1% | $7.77M+470% | $1.36M-80.0% | $6.81M+4,001% | $166K+792% | ||
| $7.92M+1.0% | $7.84M-3.4% | $8.11M+7.8% | $7.53M+1.2% | $7.44M-1.1% | ||
| —— | $0-100% | $1.88M-50.0% | $3.76M-33.3% | $5.64M-25.0% | ||
| -$11.9M-1.4% | -$11.73M-2.2% | -$11.47M-3.7% | -$11.06M-2.7% | -$10.76M-0.2% | ||
| —— | —— | $9.05M+757% | $1.06M+121% | -$5.01M+46.4% | ||
| —— | —— | —— | -$9.96M-450% | $2.85M-43.0% | ||
| $155.88M+22.4% | $127.3M-16.9% | $153.26M+3.7% | $147.75M-9.7% | $163.69M-12.8% | ||
| $41.68M+3.1% | $40.42M-3.3% | $41.79M+2.2% | $40.91M+5.8% | $38.68M+6.1% | ||
| -$60.49M-0.2% | -$60.36M-1.4% | -$59.51M-1.6% | -$58.57M-4.2% | -$56.19M-6.4% | ||
| $16.36M-3.0% | $16.87M+9.3% | $15.43M+14.0% | $13.54M-0.7% | $13.64M+1.7% | ||
| $7.9M+2.8% | $7.68M+6.0% | $7.25M+5.2% | $6.89M+5.8% | $6.51M+34.9% | ||
| -$229.06M-0.7% | -$227.41M+50.8% | -$461.84M-91.0% | -$241.86M+2.1% | -$247.02M-3.3% | ||
| $1.19M-69.0% | $3.85M+446% | $705K-70.5% | $2.39M+489% | $405K+124% | ||
| —— | —— | -$367.44M-150% | -$146.74M-8.2% | -$135.56M-32.4% | ||
| $2.41M-9.0% | $2.65M-12.4% | $3.03M-8.5% | $3.31M-6.9% | $3.55M-6.2% | ||
| -$499K-2.3% | -$488K+49.9% | -$974K+7.1% | -$1.05M+0.1% | -$1.05M-7.4% | ||
| —— | $0— | $0— | $0— | $0— | ||
| —— | $599K+33.3% | $449.25K+50.0% | $299.5K+100% | $149.75K— | ||
| —— | —— | —— | -$9.96M-450% | $2.85M-43.0% | ||
| —— | —— | —— | —— | $4.6M-46.2% | ||
| $7.49M-26.4% | $10.17M+87.0% | $5.44M+26.1% | $4.31M-56.0% | $9.79M-11.0% | ||
| -$11.9M-1.4% | -$11.73M-2.2% | -$11.47M-3.7% | -$11.06M-2.7% | -$10.76M-0.2% | ||
| —— | —— | $9.05M+757% | $1.06M+121% | -$5.01M+46.4% | ||
| $1.7M-9.0% | $1.87M— | —— | —— | —— | ||
| —— | —— | —— | $2M-73.5% | $7.57M+238% | ||
| $6.9M-11.1% | $7.77M+470% | $1.36M-80.0% | $6.81M+4,001% | $166K+792% | ||
| $7.92M+1.0% | $7.84M-3.4% | $8.11M+7.8% | $7.53M+1.2% | $7.44M-1.1% | ||
| —— | $2.43M+33.3% | $1.82M+50.0% | $1.22M+100% | $607.5K— | ||
| $16.38M-6.5% | $17.52M-1.1% | $17.72M+0.3% | $17.66M+0.8% | $17.51M+7.3% | ||
| —— | $0-100% | $97.75M-50.0% | $195.5M-33.3% | $293.25M-25.0% | ||
| —— | $0-100% | $181.75K-50.0% | $363.5K-33.3% | $545.25K-25.0% | ||
| $16.36M-3.0% | $16.87M+9.3% | $15.43M+14.0% | $13.54M-0.7% | $13.64M+1.7% | ||
| $24.17M-3.7% | $25.1M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$11.9M-1.4% | -$11.73M-2.2% | -$11.47M-3.7% | -$11.06M-2.7% | -$10.76M-0.2% | ||
| $114.2M+31.4% | $86.89M-22.1% | $111.47M+4.3% | $106.84M-14.5% | $125.02M-17.4% | ||
| $114.2M+31.4% | $86.89M-22.1% | $111.47M+4.3% | $106.84M-14.5% | $125.02M-17.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Omnicell generate?
- Omnicell (OMCL) generated $155.9M in operating cash flow over the trailing twelve months.
- What is Omnicell's free cash flow?
- After $41.7M of capital expenditures, Omnicell's free cash flow was $114.2M over the trailing twelve months, down 8.6% year over year.
- Where does Omnicell's cash flow data come from?
- Every line is extracted from Omnicell's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
